Expert Review of Pharmacoeconomics & Outcomes Research

Scope & Guideline

Advancing Knowledge at the Intersection of Economics and Outcomes

Introduction

Explore the comprehensive scope of Expert Review of Pharmacoeconomics & Outcomes Research through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Expert Review of Pharmacoeconomics & Outcomes Research in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1473-7167
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationEXPERT REV PHARM OUT / Expert Rev. Pharmacoecon. Outcomes Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Expert Review of Pharmacoeconomics & Outcomes Research focuses on the critical evaluation of pharmacoeconomic studies and their implications for healthcare outcomes. Its scope encompasses a wide range of topics related to health economics, cost-effectiveness analysis, and the impact of healthcare interventions on patient outcomes.
  1. Pharmacoeconomics:
    The journal publishes comprehensive analyses of the economic aspects of drug therapies, including cost-effectiveness and budget impact analyses, to inform healthcare decision-making.
  2. Health Technology Assessment (HTA):
    Research on the methodologies and applications of HTA in evaluating the value of new health technologies, drugs, and interventions to guide policy and reimbursement decisions.
  3. Patient-reported Outcomes:
    Studies focusing on measuring and valuing health-related quality of life and patient-reported outcomes, which are critical for assessing the impact of treatments from the patient's perspective.
  4. Comparative Effectiveness Research:
    Analysis comparing the effectiveness, safety, and cost of different therapeutic interventions to provide evidence for clinical guidelines and policy-making.
  5. Digital Health and Innovation:
    Exploration of the economic implications of digital health technologies and innovations, including their role in improving medication adherence and patient outcomes.
  6. Global Health Economics:
    Research addressing pharmacoeconomic evaluations in various global contexts, particularly in low- and middle-income countries, to understand the broader implications of healthcare interventions.
The journal has seen a rise in interest in several emerging themes that align with contemporary challenges in pharmacoeconomics and healthcare delivery.
  1. Integration of Machine Learning and AI:
    There is a growing trend towards utilizing machine learning and artificial intelligence in health economic evaluations, offering novel approaches to predict outcomes and enhance decision-making.
  2. Value-Based Healthcare Models:
    An increased focus on value-based healthcare, with research exploring how to align reimbursement models with patient outcomes and overall healthcare value.
  3. Real-World Evidence (RWE):
    The importance of real-world evidence is gaining traction, with studies emphasizing the need to assess the effectiveness and economic impact of interventions in everyday clinical settings.
  4. Patient Engagement in Research:
    Emerging themes include the engagement of patients in the development of health economic evaluations, emphasizing the importance of incorporating patient preferences and experiences.
  5. Sustainability and Environmental Considerations:
    A new focus on incorporating sustainability metrics into health economic evaluations, addressing the environmental impact of healthcare interventions.
  6. Cross-Disciplinary Approaches:
    An increase in interdisciplinary research that combines insights from economics, public health, and clinical practice to address complex healthcare challenges.

Declining or Waning

While the journal has maintained a robust focus on pharmacoeconomics and health outcomes, certain themes appear to be waning in prominence based on recent publications.
  1. Traditional Cost-Utility Analyses:
    There is a noticeable decline in studies solely relying on traditional cost-utility analyses without integrating broader health economic perspectives or real-world evidence.
  2. Focus on Localized Studies:
    The emphasis on localized pharmacoeconomic studies is decreasing, with a shift towards more globally relevant research that can inform international health policies.
  3. Single Disease Focus:
    Research concentrating on singular diseases is becoming less common, as the journal increasingly favors studies that incorporate multi-condition perspectives or address comorbidities.
  4. Outdated Methodologies:
    There is a decline in the publication of studies utilizing outdated economic evaluation methodologies, as the field evolves towards more sophisticated and innovative approaches.
  5. Static Policy Evaluations:
    Research that merely evaluates existing policies without proposing actionable insights or innovations is becoming less prevalent, reflecting a need for more dynamic and forward-thinking analyses.

Similar Journals

Farmeconomia-Health Economics and Therapeutic Pathways

Driving the future of health economics with open access knowledge.
Publisher: SEED MEDICAL PUBLISHERSISSN: 1721-6915Frequency: 1 issue/year

Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.

HEALTH TECHNOLOGY ASSESSMENT

Driving impactful research in health policy and technology.
Publisher: NIHR JOURNALS LIBRARYISSN: 1366-5278Frequency:

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

MEDICAL DECISION MAKING

Transforming theory into practice for healthcare excellence.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Applied Health Economics and Health Policy

Exploring the nexus of health policy and economic impact.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

VALUE IN HEALTH

Championing Evidence to Enhance Public Health Strategies
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

AMERICAN JOURNAL OF MANAGED CARE

Elevating health policy discourse for a better tomorrow.
Publisher: MANAGED CARE & HEALTHCARE COMMUNICATIONS LLCISSN: 1088-0224Frequency: 12 issues/year

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

Journal of Pharmaceutical Health Services Research

Elevating the standards of pharmaceutical health services research.
Publisher: OXFORD UNIV PRESSISSN: 1759-8885Frequency: 4 issues/year

Journal of Pharmaceutical Health Services Research, published by Oxford University Press, stands as a vital resource within the fields of pharmacology, toxicology, and health economics. With a focus on the integration of pharmaceutical science and healthcare services, this journal addresses the rapidly evolving challenges faced by researchers and practitioners alike, promoting innovative solutions that can enhance patient care and improve health outcomes. Its Q3 ranking in key categories such as Economics and Pharmacology further highlights its significance in the academic landscape. Although not an open-access journal, the Journal of Pharmaceutical Health Services Research provides a platform for high-quality research and comprehensive reviews, making it an essential reference for those dedicated to advancing knowledge and practice in pharmaceutical health services. With converged years from 2010 to 2024, the journal continues to contribute valuable insights that foster collaboration among academics, industry professionals, and policymakers, reinforcing its role as a cornerstone of pharmaceutical research and health service innovation.

Journal of Comparative Effectiveness Research

Empowering decisions with comparative effectiveness research.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

European Journal of Health Economics

Transforming Health Policy Through Economic Insight
Publisher: SPRINGERISSN: 1618-7598Frequency: 4 issues/year

The European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.

British Journal of Surgery

Shaping the landscape of modern surgery.
Publisher: OXFORD UNIV PRESSISSN: 0007-1323Frequency: 13 issues/year

The British Journal of Surgery, published by OXFORD UNIV PRESS, stands as a preeminent periodical in the field of surgery, as evidenced by its impressive impact factor and esteemed ranking of #7 out of 551 in the Scopus category of Medicine - Surgery, placing it in the 98th percentile. Since its inception in 1913, the journal has dedicated itself to disseminating cutting-edge research, innovative surgical techniques, and comprehensive meta-analyses, thereby shaping the future of surgical practice and education. With a robust commitment to academic rigor, it has consistently maintained a prestigious position in the Q1 category of surgery as of 2023, affirming its relevance in the modern medical landscape. The journal provides essential access to healthcare professionals, researchers, and students passionate about advancing surgical knowledge and improving patient outcomes. Operated from its headquarters in Oxford, United Kingdom, the British Journal of Surgery is pivotal for anyone looking to stay at the forefront of surgical advancements.